Dr. Chung, along with Andrew G. Sikora, M.D., Ph.D., Sacha Gnjatic, Ph.D., and Nham Tran, Ph.D., are working to improve the immune-stimulating effects of chemo-radiotherapy (CRT) in HPV-associated head and neck cancer, by targeting the tumor microenvironment (TME). Part of their work involves analyzing tumors and peripheral blood samples from patients before and during CRT and determining its effects on circulating antibodies. They’re also using mouse models of HPV-associated head and neck cancer to test different CRT dosing regimens and see how combining CRT with an NOS (nitric oxide synthase) inhibitor, as well as a genetically engineered bacteria expressing an HPV antigen influences anti-tumor responses.
Projects and Grants
Targeting the tumor immune microenvironment to enhance immune-stimulating effects of chemoradiotherapy
Moffitt Cancer Center | Head and Neck Cancer | 2015
Let's spread the word about Immunotherapy! Click to share this page with your community.